Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annelore Altendorf-Hofmann

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
International Journal of Cancer|September 30, 2018
Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcomaMartin F Orth, Julia S Gerke, Thomas Knösel, et al.
The Journal of Experimental Medicine|February 24, 2018
ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signalingStefanie Schmidt, Neele Schumacher, Jeanette Schwarz, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
International Journal of Cancer|September 30, 2018
Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcomaMartin F Orth, Julia S Gerke, Thomas Knösel, et al.
The Journal of Experimental Medicine|February 24, 2018
ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signalingStefanie Schmidt, Neele Schumacher, Jeanette Schwarz, et al.
Pageof 6